Multifactorial Medication Mishap Case Study:
The Case A previously healthy 50-year-old man was hospitalized while recovering from an uncomplicated
spine surgery. Although he remained in moderate pain, clinicians planned to transition him from

intravenous to oral opioids prior to discharge. The patient experienced nausea with pills but told the

bedside nurse he had taken liquid opioids in the past without difficulty. The nurse informed the physician

that the patient was having significant pain, and liquid opioids had been effective in the past. When the

physician searched for liquid oxycodone in the computerized prescriber order entry (CPOE) system,

multiple options appeared on the list — two formulations for tablets and two for liquid (the standard 5 mg

per 5 mL concentration and a more concentrated 20 mg per mL formulation). At this hospital, the CPOE

system listed each choice twice, one entry with the generic name and one entry with a brand name. In all,

the physician saw eight different choices for oxycodone products. The physician chose the concentrated

oxycodone liquid product, and ordered a 5-mg dose. All medication orders at the hospital had to be

verified by a pharmacist. The pharmacist reviewing this order recognized that the higher concentration

was atypical for inpatients but assumed it was chosen to limit the volume of fluid given to the patient. The

pharmacist verified the order and, to minimize the risk of error, added a comment to both the electronic

medication administration record (eMAR) and the patient-specific label that the volume to be given was

0.25 mL (5 mg). For added safety, the pharmacist personally retrieved, labeled, and delivered the drug

and a calibrated syringe to the bedside nurse to clarify that this was a high
concentration formulation for which the volume to administer was 0.25 mL (a smaller volume than would
typically be delivered). Shortly thereafter, the nurse went to the bedside to administer the drug to the

patient for his ongoing pain. She gave the patient 2.5 mL (50 mg) of liquid oxycodone, a volume that she

was more used to giving, and then left for her break. A covering nurse checked on the patient and found

him unconscious—a code blue was called. The patient was given naloxone (an agent that reverses the

effect of opioids), and he responded well. He was transferred to the intensive care unit for ongoing

monitoring and a continuous infusion of naloxone to block the effect of the oxycodone. By the following

morning, the patient had returned to his baseline with no apparent adverse effects.
Write a 525 word-summary in which you: Explain why a root cause analysis was appropriate for this

situation.
Analyze the impact of using tools like root cause analysis (RCA),Failure Mode and Effect Analysis (FMEA),

and Plan-Do-Study-Act(PDSA) on the quality and safety of patient care.

Sample Solution

The post Multifactorial Medication Mishap RCA appeared first on homework handlers.

A topic relating to international business practices will be selected early in the semester
and will be approved by the instructor prior to the submission date. Library and internet
research are required for this written project and the format should adhere to the
professor’s instructions given in class. Grades will be based on thoroughness, critical
thinking, accuracy and organization.

Sample Solution

The post Major Acquisitions of luxury brands and the future of the market appeared first on homework handlers.